How product innovation is shaping the future clinical trial - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

How product innovation is shaping the future clinical trial

01 Nov 2021

E.K. Koh, Chief Product Officer at Suvoda, on the different ways eClinical technology innovations are simplifying trial complexity for patients, site managers and sponsors

Sponsored by Suvoda Sponsored by Visit Company
How product innovation is shaping the future clinical trial

What have you learned from working in product innovation in other industries that you can bring to improve clinical trials?

Two things drive innovation. One is new technology that enables an existing problem to be solved differently in perhaps a much more efficient way. The other is shifts in markets which create new pain points, new opportunities, that we can now apply technology to. Those are the key drivers for innovation, and they apply to most markets, whether it is the clinical trial market, the broader healthcare market, financial services, or anything else. So, I think the experience I have driving innovation in other industries is very applicable here — the ability to spot new technologies and how that might apply to solving the current problems differently.

Where does Suvoda see an opportunity for innovation in clinical trials?

Suvoda is focused on the efficient management of patient and drug supply logistics in a clinical trial. There are a lot of opportunities to improve on both through continuous innovation in those areas. One way is to make the patient’s experience of the clinical trial much more integrated and seamless, right from enrolling them to the trial itself to how he or she reports back on the trial as it progresses. Another area is the drug supply chain itself. There is opportunity to improve visibility of drug logistics during the course of the trial.

What specifically is Suvoda doing in these areas?

In 2018 we released direct-to-patient drug shipping, which is a step towards making it easier for patients to participate in these trials. We have also released temperature excursion management which makes it easier for drug supply managers to manage temperature-sensitive drugs through the supply chain.

We are currently focused on providing a much more integrated patient journey for our customers. If you look at a trial, it starts with onboarding the patient and all the concerns that the patient needs to be apprised of before they consent to participate. Then the patient is enrolled, screened and assigned to a treatment arm. As the trial progresses, study teams want to capture the patient’s reported outcomes. Integrating patient consent and clinical outcome assessments with our IRT is the area that we are working on to create an enhanced and seamless patient experience. The other part is to make it easier for our sponsors or site managers to have better visibility to trial metrics, enabling real-time decisions and providing greater mid-trial control.

What are future trends in product innovation that will help shape clinical trials?

A big trend for us is the decentralisation and the virtualisation of trials. It has been happening for a while, but COVID has really accelerated that trend. It’s about bringing the trial to the patient, providing that flexibility. This goes all the way from site-centric, which is where we are today and where the patient comes to the trial site to participate in the trial, to the other end of the spectrum where the patient is fully remote. I think the reality is it’s going to be somewhere in between with some elements of the trial conducted on-site while others will be conducted remotely. So that level of flexibility needs to be available to the study teams in order to be able to bring drugs to market faster in a more cost-effective and efficient manner, and available to patients to make it easier for them to participate in trials. It’s very real and attainable. We want to have the digital tools to make that possible for patients and our site managers and sponsors.

What are you most excited about in this space and your role in it with Suvoda?

It is the opportunity to drive the transformation we have discussed through a platform-based approach. We can provide that platform to enable the digitisation of different parts of the patient journey to ensure that the patient experience is optimised and to ensure that the data we collect in each part of the journey is integrated. We also have the opportunity to make it easier for sponsors and study managers to manage all the different parts of the patient journey from one integrated platform. I think that’s what’s most exciting and that’s the opportunity for Suvoda and our customers, and we’re well-positioned to do that.

Free Case Study

Case Study: Automating the IRT Receipt Process for Temperature-Monitored Shipments

The shipping of temperature-monitored drugs for clinical trials is typically plagued by delays and tends to lack visibility and consistency. Grünenthal, a research and development company focused on innovative pain treatments, came to Suvoda looking to dramatically improve their manual process.

By leveraging IRT automation, Suvoda developed an innovative solution that turned a 29-day process into a same-day one, a powerful example of how automation can improve trials. This case study outlines the process by which Suvoda helped generate this solution, along with its key findings.

By clicking the “Submit” button above, you accept the Terms & Conditions and acknowledge that your data will be used as described in the Suvoda Privacy Policy.

We will also collect and use the information you provide for carefully considered and specific purposes, where we believe we have a legitimate interest in doing so, for example to send you communications about similar products and services we offer. We will always give you an option to opt out of any future communications from us. You can find out more about our legitimate interest activity in our privacy policy here. ‘We’ includes Verdict Media Limited and other GlobalData brands as detailed here.